News, Events & Insights

Follow the latest developments in circRNA research, precision neurology, scientific collaboration, and company news.

EXPLORE OUR SCIENCECONNECT WITH US!
header image with line drawing of globe with network lines and circles in the left and right with wavy lines moving left to right.

Featured Updates

Events & Presentations
Jul 28, 2026
Register Now! Live Webinar July 28th 9AM PT │ 5:00 PM BST
Title: Advancing Alzheimer’s Biomarkers: The Role of Brain-derived Circular RNA in Blood-Based Detection and Prediction of Disease Progression
Press Releases
Jul 1, 2026
Circular Genomics Unveils Its CircPath™ Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of Alzheimer's Disease
July 1, 2026 Blood-Based Circular RNA Biomarkers Outperform Gold-Standard Tests, Enable Preclinical Risk Stratification Years Before Symptom Onset, and Open New
Press Releases
Apr 29, 2026
Circular Genomics and Vitazi.ai forge strategic alliance for early Alzheimer's detection
Circular Genomics and Vitazi.ai are partnering to pair AI retinal imaging with circRNA blood biomarkers for earlier, non-invasive Alzheimer's detection.

All Updates

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Events & Presentations
Jul 28, 2026
Register Now! Live Webinar July 28th 9AM PT │ 5:00 PM BST
Title: Advancing Alzheimer’s Biomarkers: The Role of Brain-derived Circular RNA in Blood-Based Detection and Prediction of Disease Progression
Events & Presentations
Jul 12, 2026
Alzheimer's Association International Conference
July 12-15, 2026 | The AAIC is the world’s largest and most influential forum dedicated to dementia science, convening scientists, clinical researchers, and
Press Releases
Jul 1, 2026
Circular Genomics Unveils Its CircPath™ Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of Alzheimer's Disease
July 1, 2026 Blood-Based Circular RNA Biomarkers Outperform Gold-Standard Tests, Enable Preclinical Risk Stratification Years Before Symptom Onset, and Open New
Industry Perspectives
Jun 22, 2026
The Precision Neurology Era Has Arrived
Read our article in the San Diego BusinessJournal to learn how recent research has demonstrated that blood-based circRNAsignatures can identify Alzheimer’s
Press Releases
Apr 29, 2026
Circular Genomics and Vitazi.ai forge strategic alliance for early Alzheimer's detection
Circular Genomics and Vitazi.ai are partnering to pair AI retinal imaging with circRNA blood biomarkers for earlier, non-invasive Alzheimer's detection.
Press Releases
Apr 24, 2026
Circular Genomics Appoints World-Renowned Expert in Neurochemistry and Alzheimer's Fluid Biomarkers Dr. Henrik Zetterberg to Scientific Advisory Board
Leading Alzheimer's Disease Researcher Joins to Advance Circular RNA Blood-Based Biomarker Platform for Neurodegenerative Diseases
Podcasts
Apr 3, 2026
Healthcare Happenings Podcast: Cracking the Brain Code with Circular RNA
Healthcare Happenings Podcast: Cracking the Brain Code with Circular RNA
Press Releases
Feb 10, 2026
Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Bood Test for Alzheimer's Disease
Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory pathways for next-generation molecular diagnostics in neurolo
Press Releases
Dec 8, 2025
Circular Genomics Strengthens Scientific Advisory Board with the Addition of Esteemed Alzheimer's Experts
Michael Weiner, MD and Timothy Hohman, PhD, bring decades of experience in neurological diseases with a focus on Alzheimer's disease
Dec 1, 2025
Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-In-Class Circular RNA Platform for Early Detection of Alzheimer's Disease
Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-cla
Press Releases
Nov 24, 2025
Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer's Disease at CTAD 2025
New clinical data highlights circular RNAs (circRNAs) as a novel, non-invasive blood biomarker platform for the early detection of Alzheimer's Disease (AD). The
Press Releases
Jul 8, 2025
Circular Genomics Receives $250K Investment from the Alzheimer's Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of AD
SAN DIEGO, July 8, 2025 -- Circular Genomics, Inc., a global leader in circular RNA (circRNA) biomarkers for precision neurology and psychiatry, today announced
Press Releases
Jun 18, 2025
Circular Genomics Announces Formation of its Commercial Advisory Board with Veteran Industry Leaders
Andrew Lechleiter, Laura Viaches, Melissa Reilly, and James Grana bring decades of senior leadership across the healthcare industry
Events & Presentations
Apr 22, 2025
Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"
Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"
Press Releases
Mar 19, 2025
Circular Genomics Strengthens Scientific Advisory Board with Addition of Alzheimer's Disease Expert
Phyllis Barkman Ferrell, MBA, DrPH, brings decades of experience in neurological conditions with a focus on Alzheimer's disease
Press Releases
Mar 17, 2025
Circular Genomics Joins Lilly Gateway Labs in San Diego to Develop Its Best-In-Class Circular RNA Platform for the Diagnosis and Prognosis of Alzheimer's Disease
Circular Genomics' move to the Lilly Gateway Labs community will enhance scientific collaboration and innovation to foster the development of its Alzheimer's di
Industry Perspectives
Mar 13, 2025
5 Promising RNA Biotech Companies To Watch in 2025
Circular Genomics: Innovative RNA Solutions to Lead a New Era in Mental Health
Industry Perspectives
Nov 12, 2024
Precision Psychiatry: A Paradigm Shift for Mental Healthcare
While medicine has traditionally aimed to be personalized, it has rarely been precise.
Industry Perspectives
Nov 5, 2024
Bringing precision medicine to psychiatry: circular RNAs as a window into the brain
Circular Genomics has created the first ever circular RNA-based test to predict a patient’s response to selective serotonin-reuptake inhibitor antidepressant tr
Industry Perspectives
Sep 17, 2024
Circular Genomics launches antidepressant response test
The new SSRI antidepressant test uses circular RNA biomarkers to improve precision in psychiatry.
Press Releases
Sep 16, 2024
Circular Genomics Announces Launch of MindLight™, the First SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
MindLight™ identifies the presence of a circular RNA biomarker that can predict the likelihood of response to SSRI medication for patients diagnosed with depres
Industry Perspectives
Aug 6, 2024
How Circular Genomics is using genetics to stop depression meds being a guessing game
NEW MEXICO (KRQE) – More Americans are suffering from depression, according to a Gallup study conducted in 2023. The study also found that minorities experience
Industry Perspectives
Jul 23, 2024
Circular Genomics uses RNA to stop depression meds being a guessing game
October 18, 2022 (TechCrunch) -- For many people who live with depression, medication is an important part of managing the condition. But knowing which will wor
Press Releases
May 7, 2024
Circular Genomics Announces New Research Demonstrating Accuracy of circRNA-based Test for Predicting Response to SSRI Antidepressant Treatment
Circular RNA blood biomarker identified in EMBARC study and validated in naturalistic clinical study distinguishes future responders and non-responders to SSRIs
Press Releases
Mar 18, 2024
Circular Genomics Adds Dr. Michael Ackermann, PhD, MBA to its Scientific Advisory Board
Albuquerque, N.M., March 18, 2024 - Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced the
Press Releases
Feb 26, 2024
Circular Genomics Strengthens Leadership Team with Key Commercial and Research Hires
New appointments hired in preparation for the launch of the world's first circular RNA-based clinical prediction test for antidepressant therapies.
Press Releases
Jan 24, 2024
Circular Genomics Raises $8.3 Million for Debut of Circular RNA Assay in Precision Psychiatry
Albuquerque, New Mexico, January 24, 2024 - Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, to
Press Releases
Sep 5, 2023
Circular Genomics Announces Partnership on Alzheimer's Disease Biomarker Research
Albuquerque, New Mexico – Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry, has announced a partnership with leading Alz
Press Releases
Aug 17, 2023
Circular Genomics Announces Ron Rocca as Board Member
Albuquerque, New Mexico – Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry, has announced the expansion of its board of
Industry Perspectives
Jul 27, 2023
Circular Genomics Readying to Launch Zoloft Response Diagnostic Based on Circular RNA Biomarker
NEW YORK, NY., July 27, 2023 (GenomeWeb) -- Molecular diagnostics startup Circular Genomics has identified a new biomarker that can predict which patients are l
Press Releases
Jul 11, 2023
Circular Genomics Announces Two Significant Steps Forward in Linking CircRNA to Major Depression
Albuquerque, NM, July 11, 2023 (GLOBE NEWSWIRE) -- Circular Genomics, the global leader in the use of circular RNA (circRNA) biomarkers for precision psychiatry
Industry Perspectives
Jul 5, 2023
Circular Genomics Sees More Direct PGx Assay Through Brain-Derived Circular RNA
NEW YORK, NY., June 05, 2023 (GenomeWeb) -- Molecular diagnostics startup Circular Genomics sees a more direct way to predict patient response to psychiatric me
Press Releases
Apr 27, 2023
Precision Medicine in Mental Health Company, Circular Genomics, Appoints, Dr. Paul Sargeant as CEO
ALBUQUERQUE, N.M., April 27, 2023 /PRNewswire/ -- Circular Genomics, the leading company in developing circular RNA-based precision medicine tools, data and dia
Press Releases
Dec 14, 2021
Circular Genomics Closes $4.5M Series Seed Investment
December 14, 2021 – Circular Genomics, an Albuquerque, New Mexico-based circRNA company, is pleased to announce the closing of their $4.5M Series Seed investmen

Be the First to Hear What's Next

Receive updates on new publications, conference presentations, webinars, research collaborations, and company announcements.

Subscribe for UpdatesContact Us
10935 Alexandria Way, Suite 201
San Diego, CA 92121
info@circulargenomics.com
Privacy PolicyTerms of UseCookie Policy
Careers
Follow Our Work
Watch our 2-minute video
Interested in our research or partnering with us?
Contact
© 2026 Circular Genomics, Inc. All rights reserved.